Two in five practicing physicians are equal parts enthused over and worried about AI in healthcare. That’s the same ratio the American Medical Association turned up the last time it conducted its Physician Sentiment Survey.

An international cluster of 117 researchers from 50 countries has arrived at a consensus on six principles that, in the team’s considered view, ought to guide the use of AI across healthcare worldwide. 

Standing FDA guidance reflects concern over physicians deferring to AI-aided CDS recommendations when pressed for time or uncertain of their own judgments. Is that stance outdated? 

Frank Kryzak has filed a lawsuit against Northwestern Medicine McHenry Hospital after an exploratory surgery allegedly left him in a mysterious state of agony for four months. 

While there have been no reported injuries, a manufacturing error involving debris contamination could potentially kill a patient.

A new post-stroke care pathway from Viz.ai and Medtronic is associated with significant benefits, including higher patient and clinician satisfaction.

More than 100 incidents have been reported so far. The FDA is still evaluating this issue, but the agency wanted to raise awareness as quickly as possible.

Last summer more than 40% of 121 hospital executives surveyed said their organization had already realized a decent ROI in generative AI. However, a C-suite slice of nearly the same size said it was too soon to know for sure.